Dataset from Discovery and Validation of Proteogenomic Biomarker Panels in a Prospective Serial Blood and Urine Monitoring Study of Liver Transplant Recipients - Transplant Proteogenomics

The main focus of this study is to develop blood and/or urine tests that will help to detect
early signs of rejection in people who have had a liver transplant. Researchers will examine
blood, urine, and tissue samples and try to identify markers for certain conditions such as
rejection, response to therapy, and scarring of the liver. Additionally, researchers would
like to identify biomarkers that can detect damage to the native kidneys before blood levels
of creatinine rises. By studying gene expression, researchers hope to be able to diagnose
these conditions earlier and improve liver survival.